Kindeva announces the appointment of David Stevens as President

Woodbury, Minnesota – 24 October 2025 – Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global operations.

With over 20 years of experience in the CDMO industry, David has led high-performing teams across biologics, sterile, and drug-product manufacturing. His insight and customer-centric approach will guide Kindeva’s continued growth and success.

“It’s an honor to take on this role at such an exciting time for Kindeva,” said David Stevens, President of Kindeva. “I look forward to working closely with the Kindeva team and our customers to advance our mission and drive the next chapter of our growth story.”

“David has been a pivotal leader, driving Kindeva’s growth and commitment to customers over the past three years,” said Milton Boyer, CEO of Kindeva. “The elevation of David to the role of President reflects the continued evolution of Kindeva and will enable us to build on our strong momentum, enhance our strategic focus, and continue delivering for our partners and patients worldwide.”

About Kindeva

At Kindeva, we Manufacture More Tomorrows™ for patients worldwide. With best-in-class facilities and comprehensive CDMO services, we offer more than manufacturing—we deliver strategic value. Our global network of 10 manufacturing and R&D sites offer exceptional integrated knowledge and capabilities, including Annex 1-compliant state-of-the-art aseptic fill finish capacity and next-generation sustainable inhalation propellant technology. By combining expertise in injectable, pulmonary, nasal and dermal drug delivery, we help meet the demands of today and deliver the possibilities of tomorrow.